Search

everythinglearnresearchcommunity

for

Search:↓

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

PRP injection therapy shows promise for treating hair loss, increasing hair count and thickness with minimal side effects.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Skin symptoms can indicate endocrine disorders and have various treatments.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

The book explains the science of tissue repair and regeneration, its medical uses, challenges, and ethical concerns.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Hair restoration surgery techniques can effectively treat scalp deformities and have evolved to provide natural-looking results.

Storing hair follicles in a special buffer with certain inhibitors can increase hair growth and improve transplant results.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Oral contraceptives may cause significant hair loss in women.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair follicles can regrow in wounded adult mouse skin using a process like embryo development.

Removing the ATR gene in adult mice causes rapid aging and stem cell loss.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.